Page last updated: 2024-10-24

leukocyte proliferation

Definition

Target type: biologicalprocess

The expansion of a leukocyte population by cell division. [GOC:add]

Leukocyte proliferation is a fundamental process in the immune system, ensuring the generation of sufficient immune cells to combat infections and maintain immune homeostasis. It involves a complex series of events, starting with the activation of quiescent leukocytes by various stimuli, including cytokines, pathogen-associated molecular patterns (PAMPs), and antigen presentation. This activation triggers intracellular signaling cascades that induce the expression of genes required for cell cycle progression, ultimately leading to DNA replication and cell division.

The process can be broadly divided into distinct phases:

1. **G0 phase (Quiescence):** Leukocytes in this phase are not actively dividing and are in a resting state. They maintain their basic cellular functions but do not proliferate.

2. **G1 phase (Gap 1):** Upon receiving activation signals, leukocytes enter the G1 phase. This phase is characterized by increased metabolic activity, protein synthesis, and the accumulation of cellular components required for DNA replication.

3. **S phase (Synthesis):** In this phase, DNA replication occurs, ensuring that each daughter cell receives a complete set of genetic material.

4. **G2 phase (Gap 2):** Following DNA replication, cells enter G2, a period of further growth and preparation for mitosis.

5. **M phase (Mitosis):** This phase involves the separation of duplicated chromosomes and the division of the cell into two daughter cells. Each daughter cell inherits a complete set of chromosomes and is capable of further proliferation or differentiation into specialized immune cells.

Leukocyte proliferation is tightly regulated by a complex interplay of signaling pathways, transcription factors, and cell cycle checkpoints. This regulation ensures that proliferation occurs only when necessary and prevents uncontrolled cell division, which can lead to immune dysregulation and disease.

During inflammation, leukocytes such as neutrophils, macrophages, and lymphocytes undergo rapid proliferation to increase their numbers and mount an effective immune response. This process is crucial for clearing pathogens and promoting tissue repair.

However, dysregulation of leukocyte proliferation can also lead to pathological conditions. For example, uncontrolled proliferation of leukocytes can contribute to the development of autoimmune diseases, leukemia, and other cancers.

Understanding the intricate mechanisms of leukocyte proliferation is essential for developing effective therapies for various immune-mediated diseases and for understanding the fundamental principles of immune system function.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Ubiquitin carboxyl-terminal hydrolase BAP1A ubiquitin carboxyl-terminal hydrolase BAP1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92560]Homo sapiens (human)
Proteinase-activated receptor 2A proteinase-activated receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P55085]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
triptolidediterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound
antispermatogenic agent;
plant metabolite
5-(1,3-benzodioxol-5-yl)-N-(2-furanylmethyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamidepyrazolopyrimidine
N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(5-methyl-2-propan-2-ylphenoxy)acetamidepiperazines
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamideseryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide: a proteinase-activated receptor-2-activating peptide; SL-NH2 is NOT Ser-Leu-NH2 here
2-furoyl-ligrlo-amide2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist
AZ3451benzimidazoles;
benzodioxoles;
nitrile;
organobromine compound;
secondary carboxamide
anti-inflammatory agent;
autophagy inducer;
PAR2 negative allosteric modulator
4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl esteramidobenzoic acid